Thus, we undertook this study to evaluate if variation in expression of NF-κB transcription factors, specifically tumor expression of p65 (a major contributor to canonical signaling) and p52 (a major contributor to non-canonical signaling), was associated with survival outcomes among a retrospective cohort of ovarian cancer cases. The gene discussed is NFKB2; the disease is ovarian carcinoma.